--- title: "JBIO.US (JBIO.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/JBIO.US/news.md" symbol: "JBIO.US" name: "JBIO.US" parent: "https://longbridge.com/en/quote/JBIO.US.md" datetime: "2026-03-05T23:57:44.095Z" locales: - [en](https://longbridge.com/en/quote/JBIO.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/JBIO.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/JBIO.US/news.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/JBIO.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/JBIO.US/news.md) # JBIO.US (JBIO.US) — Related News ### [Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening](https://longbridge.com/en/news/277438770.md) *2026-03-02T09:27:24.000Z* > Wisdom Bioscience, a biotechnology company focused on non-invasive oral cancer diagnostics, has established a Scientific ### [Jade Biosciences Touts “Best-in-Class” Autoimmune Antibodies, JADE101 Phase 1 Readout Nears](https://longbridge.com/en/news/277317625.md) *2026-02-28T16:41:34.000Z* > Jade Biosciences (NASDAQ: JBIO) presented its strategy and milestones at the Oppenheimer Life Sciences Conference, focus ### [Jade Biosciences to Present at Major Healthcare Conferences](https://longbridge.com/en/news/275600012.md) *2026-02-11T12:00:25.000Z* > Jade Biosciences Inc. (Nasdaq: JBIO) will present at several healthcare conferences in 2026, including the Oppenheimer 3 ### [Jade Biosciences to Present at J.P. Morgan Healthcare Conference](https://longbridge.com/en/news/271508800.md) *2026-01-05T12:00:38.000Z* > Jade Biosciences Inc. will present its company overview and 2026 outlook at the 44th Annual J.P. Morgan Healthcare Confe ### [JBIO Surges Over 75% In Just Two Months On Pipeline Momentum - Did You Take The Bet?](https://longbridge.com/en/news/269993856.md) *2025-12-17T10:18:43.000Z* > Jade Biosciences Inc. (JBIO) shares have surged over 75% in two months due to progress in its clinical programs for auto ### [Versant Venture Management LLC Invests $15.24 Million in Jade Biosciences, Inc. $JBIO](https://longbridge.com/en/news/266765606.md) *2025-11-20T14:04:19.000Z* > Versant Venture Management LLC invested $15.24 million in Jade Biosciences, acquiring 1,525,820 shares, making it a sign ### [Jade Biosciences Advances Autoimmune Therapies](https://longbridge.com/en/news/266009943.md) *2025-11-15T04:15:28.000Z* > Jade Biosciences, Inc. reported a Q3 net loss of $25.2 million, attributed to increased R&D expenses. The company bolste ### [Jade Biosciences Files For Offering Of Up To 16.1 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing](https://longbridge.com/en/news/265984153.md) *2025-11-14T21:17:13.000Z* > Nov 14 (Reuters) - Jade Biosciences Inc:* JADE BIOSCIENCES INC FILES FOR OFFERING OF UP TO 16.1 MILLION SHARES OF COMMON